Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish.

Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.75). 01/2007; 26(51):13400-10. DOI: 10.1523/JNEUROSCI.4332-06.2006
Source: PubMed

ABSTRACT As many as 10% of humans suffer chronic sleep disturbances, yet the genetic mechanisms that regulate sleep remain essentially unknown. It is therefore crucial to develop simple and cost-effective vertebrate models to study the genetic regulation of sleep. The best characterized mammalian sleep/wake regulator is hypocretin/orexin (Hcrt), whose loss results in the sleep disorder narcolepsy and that has also been implicated in feeding behavior, energy homeostasis, thermoregulation, reward seeking, addiction, and maternal behavior. Here we report that the expression pattern and axonal projections of embryonic and larval zebrafish Hcrt neurons are strikingly similar to those in mammals. We show that zebrafish larvae exhibit robust locomotive sleep/wake behaviors as early as the fifth day of development and that Hcrt overexpression promotes and consolidates wakefulness and inhibits rest. Similar to humans with insomnia, Hcrt-overexpressing larvae are hyperaroused and have dramatically reduced abilities to initiate and maintain rest at night. Remarkably, Hcrt function is modulated by but does not require normal circadian oscillations in locomotor activity. Our zebrafish model of Hcrt overexpression indicates that the ancestral function of Hcrt is to promote locomotion and inhibit rest and will facilitate the discovery of neural circuits, genes, and drugs that regulate Hcrt function and sleep.

Download full-text


Available from: Jason Rihel, Jul 02, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Most neuroactive drugs were discovered through unexpected behavioral observations. Systematic behavioral screening is inefficient in most model organisms. But, automated technologies are enabling a new phase of discovery-based research in central nervous system (CNS) pharmacology. Researchers are using large-scale behavior-based chemical screens in zebrafish to discover compounds with new structures, targets, and functions. These compounds are powerful tools for understanding CNS signaling pathways. Substantial differences between human and zebrafish biology will make it difficult to translate these discoveries to clinical medicine. However, given the molecular genetic similarities between humans and zebrafish, it is likely that some of these compounds will have translational utility. We predict that the greatest new successes in CNS drug discovery will leverage many model systems, including in vitro assays, cells, rodents, and zebrafish.
    Frontiers in Pharmacology 07/2014; 5:153. DOI:10.3389/fphar.2014.00153
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Perfluoroalkyl acids (PFAAs) are persistent organic contaminants that have been detected in wildlife, humans and the environment. Studies have shown that the toxicity of PFAAs is determined by the carbon chain length as well as the attached functional group. The locomotor activity of zebrafish larvae has become widely used for evaluation of chemicals with neurotoxic properties. In the present study the behavioral effects of seven structurally different PFAAs (i.e. TFAA, PFBA, PFOA, PFNA, PFDA, PFBS and PFOS) were evaluated in zebrafish larvae. Exposure to high concentrations of TFAA, PFNA, PFBS and PFOS resulted in distinct changes in behavioral patterns. Based on redundancy analysis, our results demonstrate three main factors affecting zebrafish larval locomotor behavior. The strongest effect on behavior was determined by the carbon chain length and the attached functional group. PFAAs with longer carbon chain length as well as PFAAs with attached sulfonic groups showed larger potential to affect locomotor behavior in zebrafish larvae. Also the concentration of the PFAAs determined the behavior responses. The results of the present study are in agreement with previous studies showing correlations between the chemical structure of PFAAs and the toxicological effects.
    Aquatic toxicology (Amsterdam, Netherlands) 10/2013; 144-145C:332-340. DOI:10.1016/j.aquatox.2013.10.021 · 3.51 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We characterize the effects of sleep deprivation on sleep-wake behavior, neurogenesis and stress in adult zebrafish, and describe light-induced changes in gene expression. Sleep deprivation was performed using two stimuli: mild electroshock and light. Comparisons were made between five groups of fish: naïve; electroshock sleep-deprived and yoked-control; fish exposed to constant light (increasing wakefulness); and fish exposed to constant darkness (increasing sleep). Behavioral parameters assessed were sleep percentage, number of sleep-wake transitions, and sleep and wake bout length. Using microarray technology, light-dark modulation of gene expression was examined. In parallel with gene expression, neurogenesis was measured and stress following sleep deprivation was assessed behaviorally and physiologically. Our results indicate that sleep duration is most effectively altered by varying exposure to ambient light. Further, while the sleep-wake dynamics are comparable to those observed in mammals, zebrafish may exhibit weaker sleep homeostasis and sleep pressure than do mammals; and sleep deprivation does not significantly alter their stress responses. Finally, modulation of gene expression by light and dark was observed. Genes upregulated during the dark period are broadly related to growth, morphogenesis, energy balance, and lipid synthesis. Genes upregulated during light are broadly related to synaptic plasticity and cell proliferation.
    Behavioural brain research 08/2013; 256. DOI:10.1016/j.bbr.2013.08.032 · 3.39 Impact Factor